Fibroscan Evaluating Immunotherapy Response in Hepatocellular Carcinoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Fibroscan Evaluating Immunotherapy Response in Hepatocellular Carcinoma — Stella

Recruiting

Back to Hepato Cellular Carcinoma (HCC) trials

Trial locations(1 site)

Egypt

Tanta University Hospitals, Tanta, Gharbyea

Key details

Sponsor

Tanta University

Enrollment target

~80 participants

Started

January 2025

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov